GH action is associated with poor prognosis in terms of overall survival and disease-free survival in many cancers, including breast cancer [15,113], liver cancer [16,114,115], colorectal cancer [116], and gastric cancer [117], among others [19]. Here, GH1 is linked to colorectal cancer.